Skip to content
Smart Bet Network

Patients Coming Off Slimming Medications Gain Back Weight Four Times Faster Than Dieters

Illustration of pharmaceutical injection and scale
Weight management often requires long-term strategies.

A recent study indicates that people who discontinue popular weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass far faster than those who end conventional lifestyle programs.

Research printed in a major medical journal points out that while overweight people often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"People purchasing such drugs must be aware of the risk of quick rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.

This pace of recovery suggests a return to original weight within about 18 months.

Comparing Approaches

The analysis, which looked at 37 of trials involving over 9,000 of participants, compared the results of GLP-1 agonists with conventional dieting.

The team note that people who lose weight through diet and exercise typically see a more gradual creep back—perhaps 100 grams monthly—once they finish.

Explaining the Rapid Regain

Doctors propose the way of the injections is key to understanding the amplified rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making overeating much more probable."

A Chronic Issue?

Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts say that, due to the high risk of relapse, the treatment is often life-long.

This perspective is echoed by drug manufacturers, who say that the findings "underscore the persistent character of obesity," comparing it to managing conditions like hypertension.

User Accounts

Individuals who have stopped the medication describe a sudden resurgence of cravings.

"I experienced a trigger activating and you become extremely hungry," recalled a patient.

This challenge is compounded if individuals have not developed sustainable lifestyle or habit changes during therapy.

Growing Interest

Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

  • Adoption is more common among women compared to males.
  • The 40s and 50s age group shows the highest usage rates.
  • Many obtain the medications through private prescriptions rather than the NHS.

Finally, researchers emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a standalone cure and long-term success hinges on integrated behavioural management.

BP
About the author

Belinda Potter

A seasoned betting analyst with over a decade of experience in sports betting markets and data-driven strategies.

Smart Bet Network

Type to search articles.